Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Beazer Homes USA M&A Deal with Dream Finders Homes, Inc.
Beazer Homes USA stockholders approved the previously announced merger agreement with Dream Finders Homes, Inc. at a special meeting held on October 15, 2026. Under the terms of the agreement, Beazer Homes will become a wholly owned subsidiary of Dream Finders Homes, with the closing expected to occur three business days after final conditions are met.
Recursion Pharmaceuticals entered into an underwriting agreement to raise approximately $200 million through a public offering of 61,540,000 shares of Class A common stock at $3.25 per share. The company also announced that Sanofi exercised an option for a first-in-class immunology development candidate under their existing collaboration, triggering a $10 million milestone payment. Proceeds from the equity raise are expected to extend the company's cash runway into 2029.
Vivos Therapeutics Signs $12M M&A Deal with SOD Sciences, Inc.
Vivos Therapeutics entered into a definitive agreement to acquire an 11% equity stake in SOD Sciences and a 50% co-ownership interest in a proprietary pseudohypoxia early-warning test. The transaction is valued at $12 million, paid via the issuance of 12,000 shares of newly created Series C Convertible Preferred Stock, and is intended to bolster stockholders' equity for Nasdaq compliance.
AtlasClear Holdings Signs $24.5M M&A Deal with Ark Financial Services, Inc.
AtlasClear Holdings has entered into a definitive agreement to acquire Ark Financial Services, the parent of investment bank Dawson James Securities, for up to $24.5 million in cash and stock. The company concurrently completed an initial 24.9% equity purchase for $5 million, with the remaining 75.1% acquisition subject to FINRA approval and other closing conditions. The deal aims to integrate a nationally ranked small-cap investment bank into AtlasClear's clearing platform, more than doubling the company's combined pro forma revenue.
Pyrophyte Acquisition Corp. II Signs $600M M&A Deal with Sakuu Corporation
Pyrophyte Acquisition Corp. II (NYSE: PAII) entered into a definitive business combination agreement to acquire Sakuu Corporation, a Silicon Valley-based energy storage manufacturing technology company. The transaction implies a pre-money equity value of $600 million for Sakuu, with the combined company expected to list on the NYSE under the ticker 'SAKU'.
Value
$600M
Counterparty
Sakuu Corporation
“Kavian technology is not only the world’s first additive manufacturing solution to dry print high-performance battery electrodes at scale; it can also dry print supercapacitor electrodes customized for the growing power needs of AI data centers. It is the only known solution for producing heavily in-demand energy products that can be custom-printed rapidly, sustainably, and cost-effectively.”
Robert Bagheri, Sakuu Founder and Chief Executive Officer
OpenWorld signed a non-binding term sheet with Meridian to establish a $1 billion tokenized financing program for a distributed AI computing network powered by solar energy and Tesla Powerwall batteries. OpenWorld will serve as the structuring agent and operator for the network, which aims to deploy compute nodes across 10,000 homes and commercial sites starting in Q4 2026.
ASP Isotopes Partnership with Nuclear Energy Corporation of South Africa SOC Limited
ASP Isotopes' subsidiary Quantum Leap Energy (QLE) signed a binding Heads of Agreement with Necsa to form a joint venture (80% QLE / 20% Necsa) to develop and operate a commercial-scale HALEU production facility in South Africa. The venture will utilize QLE's enrichment technology and Necsa's Pelindaba site infrastructure, supported by existing offtake agreements with TerraPower.
Counterparty
Nuclear Energy Corporation of South Africa SOC Limited (Necsa)
CCC Intelligent Solutions Holdings Signs $6.1B M&A Deal with GTCR and Elliott Investment Management L.P.
CCC Intelligent Solutions Holdings Inc. has entered into a definitive agreement to be acquired by a consortium led by GTCR and Elliott Investment Management in an all-cash transaction valued at approximately $6.1 billion. Stockholders will receive $7.75 per share in cash, representing a 44% premium to the company's unaffected closing price. The deal is expected to close in the first quarter of 2027, at which point CCC will become a privately held company.
Jasper Therapeutics completed enrollment for the IgA nephropathy (IgAN) cohort of its Phase 2 basket study evaluating vensobafusp alfa (KP104). The company expects to report initial interim data from this study by year-end 2026 and plans to expand the study to include patients with focal segmental glomerulosclerosis (FSGS) in early 2027.
Gibraltar Industries Divestiture to GCP Applied Technologies Inc. for $208M
Gibraltar Industries has entered into a definitive agreement to sell its Infrastructure business, The D.S. Brown Company, to GCP Applied Technologies (an affiliate of Saint-Gobain) for $208 million in cash. The divestiture is part of a strategic plan to simplify the company's portfolio and focus on building products and structures, with proceeds intended for debt reduction.
Value
$208M
Counterparty
GCP Applied Technologies Inc. (Saint-Gobain Corporation)
Krystal Biotech announced positive proof-of-concept clinical data from its Gorlin Syndrome Pilot Study evaluating KB113 for the treatment of basal cell carcinomas. The study showed that over 80% of assessed lesions regressed across three patients, including non-injected lesions, suggesting a systemic abscopal effect.
Cronos Group completed the acquisition of CanAdelaar B.V., a licensed cannabis grower in the Dutch Controlled Cannabis Supply Chain Experiment, for a base purchase price of €57.5 million plus earnouts. The deal establishes Cronos' European platform in the Netherlands' adult-use cannabis pilot program, with the buyer deducting €12.5 million from the initial price to cover a potential environmental penalty.
Esquire Financial Holdings M&A Deal with Signature Bancorporation, Inc.
Esquire Financial Holdings, Inc. completed its merger with Signature Bancorporation, Inc. on August 1, 2026, following a definitive agreement signed in March 2026. This filing serves as an amendment to provide required pro forma financial information showing the combined entity's financial condition as of March 31, 2026.
Penske Automotive Group Signs $16.3B M&A Deal with Penske Corporation and Mitsui & Co., Ltd.
Penske Automotive Group (PAG) has entered into a definitive merger agreement to be taken private by an investor group led by Penske Corporation and Mitsui & Co. for $212.00 per share in cash. The transaction values the company at an enterprise value of approximately $16.3 billion and represents an 8.84% premium to the prior day's closing price. Upon completion, expected in Q1 2027, PAG will be owned 64% by Penske and 36% by Mitsui.
Venture Global Capacity Expansion: $17.2B Investment
Venture Global entered into frame agreements with GE Vernova and Baker Hughes for the supply of up to 16 power islands and associated grid equipment to support over 10 GW of new Island-Mode power capacity. The $17.2 billion framework is designed to support the expansion of the company's LNG business and the development of adjacent, behind-the-meter large-scale data centers. This vertically integrated strategy aims to provide gigawatt-scale compute capacity without reliance on the public electric grid.
Value
$17.2B
Counterparty
GE Vernova and Baker Hughes
Term
through 2034
“By providing Island-Mode power generation, gas supply, closed-loop water systems, thousands of acres of land, data centers, and other necessary infrastructure, Venture Global is creating a vertically integrated AI utility that could solve for the many chokepoints associated with the AI buildout.”
Roku stockholders voted to approve the previously announced merger agreement with Fox Corporation, with 81.5% of outstanding shares voting in favor of the deal. Under the terms of the agreement, Roku will become a wholly owned subsidiary of Fox. Stockholders also approved the merger-related executive compensation proposal on an advisory basis.
Ocugen Licensing Deal with Roots Pharmaceutical Company WLL Worth $259M
Ocugen granted Roots Pharmaceutical an exclusive license to commercialize OCU400, a modifier gene therapy for retinitis pigmentosa, in the Middle East and North Africa. Ocugen will receive up to $4 million in upfront and development milestones, up to $255 million in sales milestones, and a 22% royalty on net sales. Ocugen also entered into a commercial supply agreement to manufacture the product for Roots.
Exascale Labs Holdings Wins $8.21M Contract from Sunon Inc.
Exascale Labs Holdings Inc. entered into a purchase and sale agreement with Sunon Inc. to provide 12 NVIDIA HGX B300 GPU servers (96 GPUs) and related networking equipment. The $8.2 million contract includes deployment services and 36 months of IT operation services for a U.S.-based data center.
Zone Frontier Divestiture to Sanzonate Holdings LLC for $3.35M
Zone Frontier Inc. sold substantially all assets of its legacy Cleaning Products Business, including its Irish subsidiary CleanCore Global Limited, to Sanzonate Holdings LLC for $3.35 million. The purchase price was paid via a secured promissory note bearing 6% interest, as the company pivots its focus toward data center and AI infrastructure interests. The buyer is controlled by Clayton Adams, a member of the company's Board of Directors.
Fox Corporation shareholders approved the issuance of Class A common stock required to complete its previously announced acquisition of Roku, Inc. The transaction involves a two-step merger where Roku will become a wholly owned subsidiary of Fox. The stock issuance proposal was approved by 99.9% of the votes cast at a special meeting of Class B common stockholders.
Verastem, Inc. entered into an underwriting agreement for a public offering of 30,937,500 shares of common stock and pre-funded warrants to purchase 312,503 shares. The common stock is priced at $8.00 per share, with the company expecting to receive net proceeds of approximately $234.7 million. The offering is expected to close on or about October 15, 2026.
The FDA has expanded the approved indication for ImmunityBio's ANKTIVA in combination with BCG to include patients with BCG-unresponsive NMIBC with papillary-only tumors. This follows the initial April 2024 approval and broadens the addressable patient population to include all patients with BCG-unresponsive NMIBC, a group that represents approximately 85% of the NMIBC population.
Mannatech, Inc. announced that it believes it has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million. The company achieved this through a corporate restructuring involving the acquisition of 100% direct ownership of Mannatech Swiss Holdings GmbH, which reduced deferred tax liabilities related to unremitted foreign earnings. Nasdaq will continue to monitor the company's compliance through its next periodic report.
Plum Acquisition Corp. IV Nasdaq/NYSE Compliance Notice
Plum Acquisition Corp. IV received a deficiency notice from Nasdaq on October 7, 2026, for failing to meet the minimum requirement of 400 total holders for continued listing on the Nasdaq Global Market. The company has 45 days to submit a compliance plan and may be granted up to 180 days to regain compliance if the plan is accepted.
Distribution Solutions Group Signs $145M M&A Deal with GradeEight Holdings, LLC
Distribution Solutions Group's subsidiary, Lawson Products, has entered into a definitive agreement to acquire GradeEight Holdings, LLC (parent of Winzer Corporation and FastServ Supply) for approximately $145 million. The acquisition adds a national MRO distribution network of over 270 franchisees and approximately $110 million in annual sales to DSG's platform. The deal is expected to close in the fourth quarter of 2026 and will be funded via the company's existing credit facility and cash.
Rent the Runway announced the expiration of the subscription period for its previously announced $15 million rights offering. Rights that were not exercised by the 5:00 p.m. ET deadline on October 14, 2026, have expired and are no longer exercisable.
Transocean Ltd. provided a regulatory update on its pending acquisition of Valaris Limited, announcing that the Brazilian competition authority (CADE) has cleared the business combination without restrictions. Once the decision becomes final following a fifteen-day waiting period, all regulatory approval conditions for the merger will be satisfied, with closing expected in the fourth quarter of 2026.
Nathans Famous M&A Deal with Smithfield Foods, Inc.
Nathan’s Famous, Inc. provided a status update on its pending merger with Smithfield Foods, Inc., disclosing that several stockholders have filed lawsuits and demand letters alleging the proxy statement was misleading. The company maintains that these claims are without merit and is proceeding toward a special stockholder meeting on October 23, 2026, to vote on the transaction.
Innovative Industrial Properties Capital Raise of $50M
Innovative Industrial Properties, Inc. entered into an underwriting agreement to sell 2,000,000 shares of its 9.25% Series B Cumulative Redeemable Preferred Stock at $25.00 per share. The company also granted underwriters a 30-day option to purchase an additional 300,000 shares, bringing the total potential offering value to $57.5 million. Net proceeds from the base offering are expected to be approximately $48.4 million.
AMASS Brands Inc. received a deficiency notice from Nasdaq on October 9, 2026, because its common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has until April 7, 2027, to regain compliance, which requires the stock to close at $1.00 or higher for at least ten consecutive business days. This notice follows a separate July 2026 warning regarding the company's failure to meet minimum market value requirements.